您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:阿克索健康2021年度报告 - 发现报告
当前位置:首页/财报/招股书/报告详情/

阿克索健康2021年度报告

2022-12-29美股财报我***
阿克索健康2021年度报告

TableofContents UNITEDSTATES SECURITIESANDEXCHANGECOMMISSIONWASHINGTON,D.C.20549 FORM20-F (MarkOne) ☐REGISTRATIONSTATEMENTPURSUANTTOSECTION12(b)OR12(g)OFTHESECURITIESEXCHANGEACTOF1934 OR ☒ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 ForthefiscalyearendedMarch31,2022 OR ☐TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Forthetransitionperiodfromto OR ☐SHELLCOMPANYREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Dateofeventrequiringthisshellcompanyreport Commissionfilenumber:001-38245 AksoHealthGroup (ExactnameofRegistrantasspecifiedinitscharter) N/A (TranslationofRegistrant’snameintoEnglish) CaymanIslands (Jurisdictionofincorporationororganization) Room515,Floor5,JiaNo.92-4to24JianguoRoadChaoyangDistrict,Beijing100020 People’sRepublicofChinaTel:+861053709902 (Addressofprincipalexecutiveoffices) Rui(Kerrie)Zhang,ChiefFinancialOfficerTelephone:+861053709902 Email:ir@xiaobaimaimai.com Room515,Floor5,JiaNo.92-4to24JianguoRoadChaoyangDistrict,Beijing100020 People’sRepublicofChina (Name,Telephone,E-mailand/orFacsimilenumberandAddressofCompanyContactPerson) SecuritiesregisteredortoberegisteredpursuanttoSection12(b)oftheAct: TitleofeachclassTradingSymbol Nameofeachexchangeonwhichregistered Americandepositaryshares(oneAmericandepositarysharerepresentingthreeordinaryshares,parvalueUS$0.0001pershare) AHGNASDAQGlobalMarket Ordinaryshares,parvalueUS$0.0001pershare*NASDAQGlobalMarket *Notfortrading,butonlyinconnectionwiththelistingoftheAmericandepositarysharesontheNASDAQGlobalMarket.SecuritiesregisteredortoberegisteredpursuanttoSection12(g)oftheAct: None (TitleofClass)SecuritiesforwhichthereisareportingobligationpursuanttoSection15(d)oftheAct: None (TitleofClass) TableofContents Indicatethenumberofoutstandingsharesofeachoftheissuer’sclassesofcapitalorcommonstockasofthecloseoftheperiodcoveredbytheannualreport. 68,598,050ordinaryshares,parvalueUS$0.0001pershare,asofMarch31,2022. Indicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct. ☐Yes☒No Ifthisreportisanannualortransitionreport,indicatebycheckmarkiftheregistrantisnotrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934. ☐Yes☒No Indicatebycheckmarkwhethertheregistrant:(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtofilesuchreports),and(2)hasbeensubjecttosuchfilingrequirementsforthepast90days. ☒Yes☐No IndicatebycheckmarkwhethertheregistranthassubmittedelectronicallyeveryInteractiveDataFilerequiredtobesubmittedpursuanttoRule405ofRegulationS-T(§232.405ofthischapter)duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtosubmitsuchfiles). ☒Yes☐No Indicatebycheckmarkwhethertheregistrantisalargeacceleratedfiler,anacceleratedfiler,anon-acceleratedfiler,oranemerginggrowthcompany.Seedefinitionof“largeacceleratedfiler,”“acceleratedfiler”and“emerginggrowthcompany”inRule12b-2oftheExchangeAct. Largeacceleratedfiler☐Acceleratedfiler☐Non-acceleratedfiler☒Emerginggrowthcompany☒ IfanemerginggrowthcompanythatpreparesitsfinancialstatementsinaccordancewithU.S.GAAP,indicatebycheckmarkiftheregistranthaselectednottousetheextendedtransitionperiodforcomplyingwithanyneworrevisedfinancialaccountingstandardsprovidedpursuanttoSection13(a)oftheExchangeAct.☒ †Theterm“neworrevisedfinancialaccountingstandard”referstoanyupdateissuedbytheFinancialAccountingStandardsBoardtoitsAccountingStandardsCodificationafterApril5,2012. Indicatebycheckmarkwhethertheregistranthasfiledareportonandattestationtoitsmanagement’sassessmentoftheeffectivenessofitsinternalcontroloverfinancialreportingunderSection404(b)oftheSarbanes-OxleyAct(15U.S.C.7262(b))bytheregisteredpublicaccountingfirmthatpreparedorissueditsauditreport.☐Yes☒No Indicatebycheckmarkwhichbasisofaccountingtheregistranthasusedtopreparethefinancialstatementsincludedinthisfiling: U.S.GAAP☒InternationalFinancialReportingStandardsasissuedOther☐bytheInternationalAccountingStandardsBoard☐ If“Other”hasbeencheckedinresponsetothepreviousquestion,indicatebycheckmarkwhichfinancialstatementitemtheregistranthaselectedtofollow. ☐Item17☐Item18 Ifthisisanannualreport,indicatebycheckmarkwhethertheregistrantisashellcompany(asdefinedinRule12b-2oftheExchangeAct). ☐Yes☒No (APPLICABLEONLYTOISSUERSINVOLVEDINBANKRUPTCYPROCEEDINGSDURINGTHEPASTFIVEYEARS) IndicatebycheckmarkwhethertheregistranthasfiledalldocumentsandreportsrequiredtobefiledbySections12,13or15(d)oftheSecuritiesExchangeActof1934subsequenttothedistributionofsecuritiesunderaplanconfirmedbyacourt. ☐Yes☐No TableofContents TABLEOFCONTENTS INTRODUCTION1 FORWARD-LOOKINGINFORMATION3 PARTI4 ITEM1.IDENTITYOFDIRECTORS,SENIORMANAGEMENTANDADVISERS4 ITEM2.OFFERSTATISTICSANDEXPECTEDTIMETABLE4 ITEM3.KEYINFORMATION4 ITEM4.INFORMATIONONTHECOMPANY58 ITEM5.OPERATINGANDFINANCIALREVIEWANDPROSPECTS96 ITEM6.DIRECTORS,SENIORMANAGEMENTANDEMPLOYEES106 ITE

你可能感兴趣

hot

阿克索健康2019年度报告

美股财报2020-08-14
hot

阿克索健康2018年度报告

美股财报2019-07-31
hot

阿克索健康2017年度报告

美股财报2018-07-30
hot

阿克索健康2022年度报告

美股财报2023-07-14
hot

阿克索健康2020年度报告

美股财报2021-07-28